These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation]. Zhu XL; Zhou XY; Zhang TM; Zhu XZ Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):87-91. PubMed ID: 16630482 [TBL] [Abstract][Full Text] [Related]
48. RET/PTC rearrangement in thyroid tumors. Nikiforov YE Endocr Pathol; 2002; 13(1):3-16. PubMed ID: 12114746 [TBL] [Abstract][Full Text] [Related]
49. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma. Borrello MG; Alberti L; Arighi E; Bongarzone I; Battistini C; Bardelli A; Pasini B; Piutti C; Rizzetti MG; Mondellini P; Radice MT; Pierotti MA Mol Cell Biol; 1996 May; 16(5):2151-63. PubMed ID: 8628282 [TBL] [Abstract][Full Text] [Related]
50. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia. Chua EL; Wu WM; Tran KT; McCarthy SW; Lauer CS; Dubourdieu D; Packham N; O'Brien CJ; Turtle JR; Dong Q J Clin Endocrinol Metab; 2000 Aug; 85(8):2733-9. PubMed ID: 10946873 [TBL] [Abstract][Full Text] [Related]
51. RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781 [TBL] [Abstract][Full Text] [Related]
52. Thyroid carcinomas in RET/PTC transgenic mice. Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006 [TBL] [Abstract][Full Text] [Related]
53. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261 [TBL] [Abstract][Full Text] [Related]
54. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas. Learoyd DL; Messina M; Zedenius J; Guinea AI; Delbridge LW; Robinson BG J Clin Endocrinol Metab; 1998 Oct; 83(10):3631-5. PubMed ID: 9768676 [TBL] [Abstract][Full Text] [Related]
55. [Oncogenes RET/PTC and mechanisms of their involvement in thyroid cancerogenesis]. Voskoboĭnyk LH Ukr Biokhim Zh (1999); 2009; 81(6):17-25. PubMed ID: 20387655 [TBL] [Abstract][Full Text] [Related]
56. High iodine concentration attenuates RET/PTC3 oncogene activation in thyroid follicular cells. Fiore AP; Fuziwara CS; Kimura ET Thyroid; 2009 Nov; 19(11):1249-56. PubMed ID: 19725779 [TBL] [Abstract][Full Text] [Related]
57. Expression of down stream molecules of RET (p-ERK, p-p38 MAPK, p-JNK and p-AKT) in papillary thyroid carcinomas. Shin E; Hong SW; Kim SH; Yang WI Yonsei Med J; 2004 Apr; 45(2):306-13. PubMed ID: 15119004 [TBL] [Abstract][Full Text] [Related]
58. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma. Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704 [TBL] [Abstract][Full Text] [Related]
59. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Klugbauer S; Rabes HM Oncogene; 1999 Jul; 18(30):4388-93. PubMed ID: 10439047 [TBL] [Abstract][Full Text] [Related]
60. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes. Klugbauer S; Pfeiffer P; Gassenhuber H; Beimfohr C; Rabes HM Genomics; 2001 Apr; 73(2):149-60. PubMed ID: 11318605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]